Recruiting

Cash Payment Program

Sponsor:

Fred Hutchinson Cancer Center

Code:

NCT06771739

Conditions

Malignant Solid Neoplasm

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Electronic Health Record Review

Interview

Support

Support

Survey Administration

Study Details

Brief summary:

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Conditions

Malignant Solid Neoplasm

Study ID

NCT06771739

Start date

Oct 1, 2026

Status verified date

Sep, 2026

Completion date

Dec 1, 2026

Anticipated

Primary completion date

Dec 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Age >= 18
  • Ability to understand English
  • Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
  • Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
  • Not current Medicaid enrollee
  • Not enrolled in hospice
  • Screens positive for financial fragility

Study Design

Enrollment

20 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Arm A (high payment schedule)

Patients receive a $1000 preloaded cash card once monthly for 3 months.

active comparator: Arm B (low payment schedule)

Patients receive a $100 preloaded cash card once monthly for 3 months.

Interventions

Electronic Health Record Review

Ancillary studies

Interview

Ancillary studies

Support

Receive $1000 preloaded cash card

Support

Receive $100 preloaded cash card

Survey Administration

Ancillary studies

Primary outcome measure

  • Participant enrollment [ Time Frame: Up to 1 year ]
  • Time to accrue 20 patients [ Time Frame: Up to 1 year ]
  • Dropout rate [ Time Frame: Up to 1 year ]
  • Survey completion rate [ Time Frame: Up to 1 year ]

Central Contacts and Locations

Central contacts

Locations

PeaceHealth St. John Medical Center

Recruiting

Longview, Washington, United States, 98632

Principal Investigator:

Kara Makin-Bond, RN, CCRP

PeaceHealth Southwest Medical Center

Recruiting

Vancouver, Washington, United States, 98664

Principal Investigator:

Kara Makin-Bond, RN, CCRP

More Information

Sponsor

Fred Hutchinson Cancer Center

Last update posted

Sep 3, 2026

Last verified

Sep, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Fred Hutchinson Cancer Center on 2026-09-03.